Literature DB >> 8958207

Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action.

H Watkins1, C E Seidman, J G Seidman, H S Feng, H L Sweeney.   

Abstract

Mutations in the beta-myosin heavy chain gene are believed to cause hypertrophic cardiomyopathy (HCM) by acting as dominant negative alleles. In contrast, a truncated cardiac troponin T (TnT) that causes HCM implies that altered stoichiometry of contractile proteins may also cause cardiac hypertrophy. Wild-type and HCM-mutant (truncated) TnT were studied in a novel quail myotube expression system. Unexpectedly, antibody staining demonstrated incorporation of both forms of human cardiac TnT into the sarcomeres of quail myotubes. Functional studies of wild type and mutant transfected myotubes of normal appearance revealed that calcium-activated force of contraction was normal upon incorporation of wild type TnT, but greatly diminished for the mutant TnT. These findings indicate that HCM-causing mutations in TnT and beta-myosin heavy chain share abnormalities in common, acting as dominant negative alleles that impair contractile performance. This diminished force output is the likely stimulus for hypertrophy in the human heart.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8958207      PMCID: PMC507702          DOI: 10.1172/JCI119063

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

Review 1.  Growth factors, proto-oncogenes, and plasticity of the cardiac phenotype.

Authors:  T G Parker; M D Schneider
Journal:  Annu Rev Physiol       Date:  1991       Impact factor: 19.318

2.  Functions of the myosin ATP and actin binding sites are required for C. elegans thick filament assembly.

Authors:  A Bejsovec; P Anderson
Journal:  Cell       Date:  1990-01-12       Impact factor: 41.582

3.  Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.

Authors:  E B Lankford; N D Epstein; L Fananapazir; H L Sweeney
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

4.  The current status of myocardial disarray in hypertrophic cardiomyopathy.

Authors:  M J Davies
Journal:  Br Heart J       Date:  1984-04

5.  Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.

Authors:  H Watkins; A Rosenzweig; D S Hwang; T Levi; W McKenna; C E Seidman; J G Seidman
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

6.  Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction.

Authors:  H L Sweeney; A J Straceski; L A Leinwand; B A Tikunov; L Faust
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

7.  Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.

Authors:  L Thierfelder; H Watkins; C MacRae; R Lamas; W McKenna; H P Vosberg; J G Seidman; C E Seidman
Journal:  Cell       Date:  1994-06-03       Impact factor: 41.582

8.  Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro.

Authors:  J Sadoshima; Y Xu; H S Slayter; S Izumo
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

9.  Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.

Authors:  G Cuda; L Fananapazir; W S Zhu; J R Sellers; N D Epstein
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

Review 10.  Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response.

Authors:  K R Chien; K U Knowlton; H Zhu; S Chien
Journal:  FASEB J       Date:  1991-12       Impact factor: 5.191

View more
  28 in total

Review 1.  Molecular genetics of cardiomyopathies.

Authors:  G Shah; R Roberts
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

Review 2.  The molecular genetic basis for hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

3.  Functional characterization of the human α-cardiac actin mutations Y166C and M305L involved in hypertrophic cardiomyopathy.

Authors:  Mirco Müller; Antonina Joanna Mazur; Elmar Behrmann; Ralph P Diensthuber; Michael B Radke; Zheng Qu; Christoph Littwitz; Stefan Raunser; Cora-Ann Schoenenberger; Dietmar J Manstein; Hans Georg Mannherz
Journal:  Cell Mol Life Sci       Date:  2012-05-29       Impact factor: 9.261

Review 4.  Tissue-Engineering for the Study of Cardiac Biomechanics.

Authors:  Stephen P Ma; Gordana Vunjak-Novakovic
Journal:  J Biomech Eng       Date:  2016-02       Impact factor: 2.097

5.  Image-guided cardiovascular functional genomics: finding the needle in the haystack.

Authors:  Sharon Cresci; Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

6.  Molecular polarity in tropomyosin-troponin T co-crystals.

Authors:  D Cabral-Lilly; L S Tobacman; J P Mehegan; C Cohen
Journal:  Biophys J       Date:  1997-10       Impact factor: 4.033

7.  An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy.

Authors:  D Fatkin; B K McConnell; J O Mudd; C Semsarian; I G Moskowitz; F J Schoen; M Giewat; C E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 8.  [Genetic causes of hypertrophic cardiomyopathy].

Authors:  H P Vosberg
Journal:  Med Klin (Munich)       Date:  1998-04-15

9.  Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice.

Authors:  D E Montgomery; J C Tardiff; M Chandra
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

10.  Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function.

Authors:  H L Sweeney; H S Feng; Z Yang; H Watkins
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.